AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 69 filers reported holding AKERO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,766,000 | -32.9% | 617,727 | 0.0% | 8.75% | +25.2% |
| Q4 2021 | $13,065,000 | -5.4% | 617,727 | 0.0% | 6.99% | +22.3% |
| Q3 2021 | $13,806,000 | -9.9% | 617,727 | 0.0% | 5.72% | +12.6% |
| Q2 2021 | $15,326,000 | -14.5% | 617,727 | 0.0% | 5.08% | +45.5% |
| Q1 2021 | $17,920,000 | -10.7% | 617,727 | -20.6% | 3.49% | +67.5% |
| Q4 2020 | $20,065,000 | -16.2% | 777,727 | 0.0% | 2.08% | -52.5% |
| Q3 2020 | $23,946,000 | -100.0% | 777,727 | -63.2% | 4.38% | -42.1% |
| Q2 2020 | $52,717,114,000 | -9.1% | 2,115,454 | -22.7% | 7.57% | -52.4% |
| Q1 2020 | $58,015,326,000 | – | 2,736,572 | – | 15.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |